carvedilol has been researched along with Diabetic Neuropathies in 2 studies
Diabetic Neuropathies: Peripheral, autonomic, and cranial nerve disorders that are associated with DIABETES MELLITUS. These conditions usually result from diabetic microvascular injury involving small blood vessels that supply nerves (VASA NERVORUM). Relatively common conditions which may be associated with diabetic neuropathy include third nerve palsy (see OCULOMOTOR NERVE DISEASES); MONONEUROPATHY; mononeuropathy multiplex; diabetic amyotrophy; a painful POLYNEUROPATHY; autonomic neuropathy; and thoracoabdominal neuropathy. (From Adams et al., Principles of Neurology, 6th ed, p1325)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Magadmi, RM | 1 |
| Alsulaimani, MA | 1 |
| Al-Rafiah, AR | 1 |
| Esmat, A | 1 |
| Akinlade, OM | 1 |
| Owoyele, B | 1 |
| Soladoye, OA | 1 |
2 other studies available for carvedilol and Diabetic Neuropathies
| Article | Year |
|---|---|
The Neuroprotective Effect of Carvedilol on Diabetic Neuropathy: An
Topics: Activating Transcription Factor 3; Animals; Carvedilol; Cell Shape; Cell Survival; Diabetic Neuropat | 2021 |
Carvedilol improves heart rate variability indices, biomarkers but not cardiac nerve density in streptozotocin-induced T2DM model of diabetic cardiac autonomic neuropathy.
Topics: Animals; Biomarkers; Carvedilol; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Heart Rate; Human | 2021 |